IL177750A0 - Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors - Google Patents

Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors

Info

Publication number
IL177750A0
IL177750A0 IL177750A IL17775006A IL177750A0 IL 177750 A0 IL177750 A0 IL 177750A0 IL 177750 A IL177750 A IL 177750A IL 17775006 A IL17775006 A IL 17775006A IL 177750 A0 IL177750 A0 IL 177750A0
Authority
IL
Israel
Prior art keywords
benzoxazocines
therapeutic use
reuptake inhibitors
monoamine reuptake
monoamine
Prior art date
Application number
IL177750A
Other languages
English (en)
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0408862A external-priority patent/GB0408862D0/en
Priority claimed from GB0408863A external-priority patent/GB0408863D0/en
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of IL177750A0 publication Critical patent/IL177750A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL177750A 2004-04-21 2006-08-29 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors IL177750A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0408862A GB0408862D0 (en) 2004-04-21 2004-04-21 Novel benzoxazocines
GB0408863A GB0408863D0 (en) 2004-04-21 2004-04-21 Novel benzoxazocines
PCT/GB2005/001519 WO2005103019A1 (en) 2004-04-21 2005-04-21 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors

Publications (1)

Publication Number Publication Date
IL177750A0 true IL177750A0 (en) 2006-12-31

Family

ID=34965745

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177750A IL177750A0 (en) 2004-04-21 2006-08-29 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors

Country Status (8)

Country Link
EP (1) EP1740558A1 (pt)
JP (1) JP2007533718A (pt)
AU (1) AU2005235786A1 (pt)
BR (1) BRPI0510075A (pt)
CA (1) CA2558741A1 (pt)
IL (1) IL177750A0 (pt)
NO (1) NO20065057L (pt)
WO (1) WO2005103019A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504960D0 (en) * 2005-03-10 2005-04-20 Arakis Ltd Benzoxazocines
GB0506835D0 (en) * 2005-04-04 2005-05-11 Arakis Ltd Therapeutic use of nefopam
US8957107B2 (en) 2009-12-15 2015-02-17 The Hospital For Sick Children Method of treating scars and β-catenin-mediated disorders using Nefopam compounds
BR112013000925A2 (pt) 2010-07-15 2020-12-01 Bayer Intellectual Property Gmbh compostos heterocíclicos como pesticidas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830803A (en) * 1965-05-10 1974-08-20 Riker Laboratories Inc 5-loweralkyl-1-phenyl-1,3,4,6-tetrahydro-5h-benz(f)-2,5-oxazocines and 4-ones
US3978085A (en) * 1975-03-07 1976-08-31 Riker Laboratories, Inc. Process for benz[f]-2,5-oxazocines
JPS5913760A (ja) * 1982-07-13 1984-01-24 Sanwa Kagaku Kenkyusho:Kk 新規の2−ベンズアゾシン誘導体及びその製法
JPS5913770A (ja) * 1982-07-13 1984-01-24 Sanwa Kagaku Kenkyusho:Kk 新規の1−フエニル−2,5−ベンゾチアゾシン誘導体及びその製法
WO2001032625A1 (en) * 1999-11-03 2001-05-10 Du Pont Pharmaceuticals Company Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
ATE404543T1 (de) * 2002-12-20 2008-08-15 Sosei R & D Ltd Benzoxazocine und ihre verwendung als monoamin- wiederaufnahme inhibitoren

Also Published As

Publication number Publication date
AU2005235786A1 (en) 2005-11-03
WO2005103019A1 (en) 2005-11-03
NO20065057L (no) 2006-11-21
JP2007533718A (ja) 2007-11-22
BRPI0510075A (pt) 2007-10-16
EP1740558A1 (en) 2007-01-10
CA2558741A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
IL191072A0 (en) Therapeutic compositions and methods
IL182734A0 (en) 4-aminotetracyclines and methods of use thereof
ZA200802501B (en) Indenoisoquinolinone analogs and methods of use thereof
ZA200701820B (en) Substituted phenylaminothiazoles and use thereof
EP1827391A4 (en) DOSAGE FORMS AND METHODS OF USE THEREOF
ZA200710858B (en) Diclofenac formulations and methods of use
GB2412729B (en) Ophthalmological apparatus
ZA200700809B (en) Corrosion-inhibiting compositions and use thereof
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
PT2589599E (pt) Novas hidroxi-6-heteroarilfenantridinas e sua utilização como inibidores de pde4
EP2097378A4 (en) NOVEL INHIBITORS OF SEH AND USE THEREOF
PL2215908T3 (pl) 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów
IL185575A0 (en) Benzoxazocines and their therapeutic use
EP1894572A4 (en) THERAPEUTIC AND / OR PROPHYLACTIC AGGREGATE AGAINST NEUROGENIC PAIN
EP1858509A4 (en) NEW CATHEPSIN C HEMMER AND ITS USE
EP1810976A4 (en) BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND THE USE THEREOF
HK1094448A (en) Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors
GB0406014D0 (en) Pharmaceutical composition and use
GB0411696D0 (en) Novel polyamines and their therapeutic use
GB0517830D0 (en) Game apparatus and game
GB0418363D0 (en) Therapeutic methods and compositions for use therein
GB0407993D0 (en) Therapeutic methods and compositions for use therein
GB0602744D0 (en) Amine and its therapeutic use
GB0517546D0 (en) Therapeutic methods and compositions
ZA200701615B (en) Novel chromen-2-one derivatives and their use as monoamine neutrotransmitter re-uptake inhibitors